annual working capital:
$360.31M+$96.12M(+36.38%)Summary
- As of today (June 17, 2025), AMPH annual working capital is $360.31 million, with the most recent change of +$96.12 million (+36.38%) on December 31, 2024.
- During the last 3 years, AMPH annual working capital has risen by +$146.00 million (+68.13%).
- AMPH annual working capital is now at all-time high.
Performance
AMPH Working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly working capital:
$388.91M+$28.60M(+7.94%)Summary
- As of today (June 17, 2025), AMPH quarterly working capital is $388.91 million, with the most recent change of +$28.60 million (+7.94%) on March 31, 2025.
- Over the past year, AMPH quarterly working capital has increased by +$89.00 million (+29.68%).
- AMPH quarterly working capital is now at all-time high.
Performance
AMPH quarterly working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Working capital Formula
Working Capital = Current Assets − Current Liabilities
AMPH Working capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +36.4% | +29.7% |
| 3 y3 years | +68.1% | +55.5% |
| 5 y5 years | +118.1% | +138.1% |
AMPH Working capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +68.1% | at high | +191.8% |
| 5 y | 5-year | at high | +118.1% | at high | +191.8% |
| alltime | all time | at high | +241.2% | at high | +372.2% |
AMPH Working capital History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $388.91M(+7.9%) |
| Dec 2024 | $360.31M(+36.4%) | $360.31M(-6.9%) |
| Sep 2024 | - | $386.94M(+11.9%) |
| Jun 2024 | - | $345.67M(+15.3%) |
| Mar 2024 | - | $299.91M(+13.5%) |
| Dec 2023 | $264.19M(-6.8%) | $264.19M(-7.3%) |
| Sep 2023 | - | $285.04M(+113.9%) |
| Jun 2023 | - | $133.27M(-55.9%) |
| Mar 2023 | - | $302.04M(+6.6%) |
| Dec 2022 | $283.46M(+32.3%) | $283.46M(+0.5%) |
| Sep 2022 | - | $282.03M(+3.1%) |
| Jun 2022 | - | $273.51M(+9.4%) |
| Mar 2022 | - | $250.05M(+16.7%) |
| Dec 2021 | $214.31M(+28.0%) | $214.31M(+4.2%) |
| Sep 2021 | - | $205.68M(+10.3%) |
| Jun 2021 | - | $186.42M(+7.7%) |
| Mar 2021 | - | $173.07M(+3.3%) |
| Dec 2020 | $167.48M(+1.4%) | $167.48M(-6.9%) |
| Sep 2020 | - | $179.82M(+3.6%) |
| Jun 2020 | - | $173.53M(+6.2%) |
| Mar 2020 | - | $163.35M(-1.1%) |
| Dec 2019 | $165.23M | $165.23M(-9.4%) |
| Sep 2019 | - | $182.31M(-0.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $183.13M(+55.0%) |
| Mar 2019 | - | $118.18M(+4.1%) |
| Dec 2018 | $113.51M(-5.9%) | $113.51M(+15.6%) |
| Sep 2018 | - | $98.18M(+19.2%) |
| Jun 2018 | - | $82.36M(-18.9%) |
| Mar 2018 | - | $101.50M(-15.8%) |
| Dec 2017 | $120.59M(-2.3%) | $120.59M(+1.3%) |
| Sep 2017 | - | $119.09M(-8.3%) |
| Jun 2017 | - | $129.88M(+9.5%) |
| Mar 2017 | - | $118.56M(-4.0%) |
| Dec 2016 | $123.48M(+6.5%) | $123.48M(-4.5%) |
| Sep 2016 | - | $129.35M(+11.8%) |
| Jun 2016 | - | $115.65M(+6.6%) |
| Mar 2016 | - | $108.52M(-6.4%) |
| Dec 2015 | $115.98M(-14.3%) | $115.98M(-9.7%) |
| Sep 2015 | - | $128.41M(-4.5%) |
| Jun 2015 | - | $134.49M(+3.1%) |
| Mar 2015 | - | $130.51M(-3.6%) |
| Dec 2014 | $135.40M(+25.9%) | $135.40M(-11.0%) |
| Sep 2014 | - | $152.10M(-3.7%) |
| Jun 2014 | - | $157.94M(+51.2%) |
| Mar 2014 | - | $104.48M(-2.9%) |
| Dec 2013 | $107.57M(+1.9%) | $107.57M |
| Dec 2012 | $105.61M | - |
FAQ
- What is Amphastar Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals annual working capital year-on-year change?
- What is Amphastar Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals quarterly working capital year-on-year change?
What is Amphastar Pharmaceuticals annual working capital?
The current annual working capital of AMPH is $360.31M
What is the all time high annual working capital for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high annual working capital is $360.31M
What is Amphastar Pharmaceuticals annual working capital year-on-year change?
Over the past year, AMPH annual working capital has changed by +$96.12M (+36.38%)
What is Amphastar Pharmaceuticals quarterly working capital?
The current quarterly working capital of AMPH is $388.91M
What is the all time high quarterly working capital for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high quarterly working capital is $388.91M
What is Amphastar Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, AMPH quarterly working capital has changed by +$89.00M (+29.68%)